Συγγραφείς:
Vassilakopoulos, T.P.
Pangalis, G.A.
Chatziioannou, S.
Papageorgiou, S.
Angelopoulou, M.K.
Galani, Z.
Kourti, G.
Prassopoulos, V.
Leonidopoulou, T.
Terpos, E.
Dimopoulou, M.N.
Sachanas, S.
Kalpadakis, C.
Konstantinidou, P.
Boutsis, D.
Stefanoudaki, E.
Kyriazopoulou, L.
Siakantaris, M.P.
Kyrtsonis, M.-C.
Variami, E.
Kotsianidis, I.
Symeonidis, A.
Michali, E.
Katodritou, E.
Kokkini, G.
Tsatalas, C.
Papadaki, H.
Dimopoulos, M.-A.
Sotiropoulos, V.
Pappa, V.
Karmiris, T.
Meletis, J.
Apostolidis, J.
Datseris, I.
Panayiotidis, P.
Konstantopoulos, K.
Roussou, P.
Rondogianni, P.
Λέξεις-κλειδιά:
cyclophosphamide; doxorubicin; prednisone; rituximab; vincristine; antineoplastic agent; cyclophosphamide; doxorubicin; prednisone; rituximab; vincristine, adolescent; adult; aged; autologous stem cell transplantation; cancer combination chemotherapy; cancer control; cancer growth; cancer prognosis; cancer radiotherapy; cancer recurrence; cancer staging; clinical feature; computer assisted emission tomography; controlled study; disease course; female; Hodgkin disease; human; large cell lymphoma; Letter; major clinical study; male; primary mediastinal large B cell lymphoma; primary tumor; priority journal; treatment response; computer assisted tomography; Lymphoma, Large B-Cell, Diffuse; Mediastinal Neoplasms; middle aged; mortality; positron emission tomography; prognosis; radiography; scintiscanning, Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Rituximab; Tomography, X-Ray Computed; Vincristine
